| For: | Agrawal S. Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma. World J Clin Oncol 2017; 8(3): 255-260 [PMID: 28638795 DOI: 10.5306/wjco.v8.i3.255] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v8/i3/255.htm |
| Number | Citing Articles |
| 1 |
Robert S O'Neill, Alina Stoita. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?. World Journal of Gastroenterology 2021; 27(26): 4045-4087 doi: 10.3748/wjg.v27.i26.4045
|
| 2 |
Veronika Šikić, Ivan Šerić, Dejan Hil, Borna Kovačić, Goran Augustin, Zrinka Požgain, Bojan Trogrlić. Diagnostic and prognostic values of pancreatic juice carbohydrate antigen 19-9 and carcinoembryonic antigen levels in patients with pancreatic cancer. World Journal of Gastrointestinal Oncology 2026; 18(5): 119610 doi: 10.4251/wjgo.v18.i5.119610
|
| 3 |
Yuefeng Zhang, Shifei Huang, Pengping Li, Qing Chen, Yongzhou Li, Yizhao Zhou, Lantian Wang, Muxing Kang, Bo Zhang, Bin Yang, Xin Dong, Yulian Wu. Pancreatic cancer-derived exosomes suppress the production of GIP and GLP-1 from STC-1 cells in vitro by down-regulating the PCSK1/3. Cancer Letters 2018; 431 doi: 10.1016/j.canlet.2018.05.027
|
| 4 |
Christina Jane Vellan, Jaime Jacqueline Jayapalan, Boon-Koon Yoong, Azlina Abdul-Aziz, Sarni Mat-Junit, Perumal Subramanian. Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A Review. International Journal of Molecular Sciences 2022; 23(4) doi: 10.3390/ijms23042093
|
| 5 |
Leonel Pekarek, Oscar Fraile‑Μartinez, Cielo Garcia‑Montero, Miguel Alvarez‑Mon, Julio Acero, Lidia Ruiz‑Llorente, Natalio García‑Honduvilla, Agustin Albillos, Julia Buján, Melchor Alvarez‑Mon, Luis Guijarro, Miguel Ortega. Towards an updated view on the clinical management of pancreatic adenocarcinoma: Current and future perspectives (Review). Oncology Letters 2021; 22(5) doi: 10.3892/ol.2021.13070
|
| 6 |
Ron Amon, Oliver C. Grant, Shani Leviatan Ben-Arye, Spandana Makeneni, Anita K. Nivedha, Tal Marshanski, Christoffer Norn, Hai Yu, John N. Glushka, Sarel J. Fleishman, Xi Chen, Robert J. Woods, Vered Padler-Karavani. A combined computational-experimental approach to define the structural origin of antibody recognition of sialyl-Tn, a tumor-associated carbohydrate antigen. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-29209-9
|
| 7 |
Zhengting Jiang, Wenjie Zhang, Gengyu Sha, Daorong Wang, Dong Tang. Galectins Are Central Mediators of Immune Escape in Pancreatic Ductal Adenocarcinoma. Cancers 2022; 14(22) doi: 10.3390/cancers14225475
|
| 8 |
AT El Gammal, JH Sturm, HO Pinnschmidt, BT Hofmann, E Bellon. Protein S100A8/A9: A Potential New Biomarker for Pancreatic Diseases. International Journal of Clinical Endocrinology and Metabolism 2017; 3(1) doi: 10.17352/ijcem.000025
|
| 9 |
Luís Ramalhete, Emanuel Vigia, Rúben Araújo, Hugo Pinto Marques. Proteomics-Driven Biomarkers in Pancreatic Cancer. Proteomes 2023; 11(3) doi: 10.3390/proteomes11030024
|
| 10 |
Hunter B. Moore, Alessandro Paniccia, Peter J. Lawson, Robert J. Torphy, Trevor L. Nydam, Ernest E. Moore, Martin D. McCarter, Richard D. Schulick, Barish H. Edil. Utility of Viscoelastic Assays Beyond Coagulation: Can Preoperative Thrombelastography Indices Predict Tumor Histology, Nodal Disease, and Resectability in Patients Undergoing Pancreatectomy?. Journal of the American College of Surgeons 2018; 227(1) doi: 10.1016/j.jamcollsurg.2018.03.031
|
| 11 |
Hui Zhang, Aixiang Liu, Xielin Feng, Lang Tian, Wentao Bo, Haiqing Wang, Yong Hu. MiR-132 promotes the proliferation, invasion and migration of human pancreatic carcinoma by inhibition of the tumor suppressor gene PTEN. Progress in Biophysics and Molecular Biology 2019; 148 doi: 10.1016/j.pbiomolbio.2017.09.019
|
| 12 |
Abinaya Elango, Vineeta Debbie Nesam, Padmaja Sukumar, Infancia Lawrence, Arunkumar Radhakrishnan. Postbiotic butyrate: role and its effects for being a potential drug and biomarker to pancreatic cancer. Archives of Microbiology 2024; 206(4) doi: 10.1007/s00203-024-03914-8
|
| 13 |
Yongjie Xie, Yang Liu, Jinsheng Ding, Guangming Li, Bo Ni, Huifang Pang, Xin Hu, Liangliang Wu. Identification of DDX31 as a Potential Oncogene of Invasive Metastasis and Proliferation in PDAC. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.762372
|